Inflarx Nv Stock Performance

IFRX Stock  USD 1.14  0.06  5.56%   
The company retains a Market Volatility (i.e., Beta) of 3.85, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, InflaRx NV will likely underperform. InflaRx NV right now retains a risk of 7.6%. Please check out InflaRx NV daily balance of power, period momentum indicator, as well as the relationship between the downside variance and total risk alpha , to decide if InflaRx NV will be following its current trending patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days InflaRx NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, InflaRx NV is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
1
InflaRx N.V. Given Consensus Recommendation of Moderate Buy by Brokerages - MarketBeat
10/03/2025
2
How geopolitical tensions affect InflaRx N.V. stock - Trade Analysis Report Expert-Curated Trade Recommendations - newser.com
10/28/2025
3
Rhythm Pharmaceuticals, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/04/2025
4
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
11/07/2025
5
InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative and Chronic Spontaneous Urticaria
11/10/2025
6
InflaRx Assessing Valuation After Positive Phase 2a Results for INF904 in HS and CSU
11/12/2025
7
Will InflaRx N.V. stock deliver strong dividend growth - July 2025 Final Week Weekly Setup with High ROI Potential - newser.com
11/19/2025
8
Risks Report Will InflaRx NV stock outperform Nasdaq index - 2025 Macro Impact Real-Time Chart Breakout Alerts - B NI V
12/05/2025
9
InflaRx N.V. Receives Consensus Rating of Moderate Buy from Analysts
12/17/2025
Begin Period Cash Flow12.8 M
Total Cashflows From Investing Activities52.4 M

InflaRx NV Relative Risk vs. Return Landscape

If you would invest  130.00  in InflaRx NV on September 26, 2025 and sell it today you would lose (16.00) from holding InflaRx NV or give up 12.31% of portfolio value over 90 days. InflaRx NV is currently generating 0.0677% in daily expected returns and assumes 7.596% risk (volatility on return distribution) over the 90 days horizon. In different words, 68% of stocks are less volatile than InflaRx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days InflaRx NV is expected to generate 1.24 times less return on investment than the market. In addition to that, the company is 10.75 times more volatile than its market benchmark. It trades about 0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

InflaRx NV Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for InflaRx NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as InflaRx NV, and traders can use it to determine the average amount a InflaRx NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0089

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskIFRX
Negative Returns
Based on monthly moving average InflaRx NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of InflaRx NV by adding InflaRx NV to a well-diversified portfolio.

InflaRx NV Fundamentals Growth

InflaRx Stock prices reflect investors' perceptions of the future prospects and financial health of InflaRx NV, and InflaRx NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on InflaRx Stock performance.

About InflaRx NV Performance

Evaluating InflaRx NV's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if InflaRx NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if InflaRx NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 759.00  721.05 
Return On Tangible Assets(0.61)(0.64)
Return On Capital Employed(0.86)(0.81)
Return On Assets(0.61)(0.64)
Return On Equity(0.75)(0.71)

Things to note about InflaRx NV performance evaluation

Checking the ongoing alerts about InflaRx NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for InflaRx NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
InflaRx NV had very high historical volatility over the last 90 days
InflaRx NV may become a speculative penny stock
The company reported the previous year's revenue of 165.79 K. Net Loss for the year was (46.06 M) with loss before overhead, payroll, taxes, and interest of (5.17 M).
InflaRx NV currently holds about 23.68 M in cash with (48.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
InflaRx NV has a poor financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: InflaRx N.V. Receives Consensus Rating of Moderate Buy from Analysts
Evaluating InflaRx NV's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate InflaRx NV's stock performance include:
  • Analyzing InflaRx NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether InflaRx NV's stock is overvalued or undervalued compared to its peers.
  • Examining InflaRx NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating InflaRx NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of InflaRx NV's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of InflaRx NV's stock. These opinions can provide insight into InflaRx NV's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating InflaRx NV's stock performance is not an exact science, and many factors can impact InflaRx NV's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.